Lack Of Follow-Up After End Of Treatment And Recurrent Viremia Among PWUD Treated For HCV Infection

Background: Despite current guidelines prioritizing people who use drugs (PWUD) to receive HCV treatment, many healthcare providers remain concerned about the possibility for re-infection after cure. An approach to mitigate this may be to identify those at particular risk and evaluate interventions to reduce its occurrence. We hypothesize that patients who attend their SVR12 appointment will have lower rates of re-infection than those who miss this appointment, as this can be understood as a function of patient stability and commitment to HCV cure. Methods: We analyzed charts of all active PWUD patients (drug use

Download abstract Download Poster